Benzinga | Jan 28, 2022 06:21AM EST

SVB Leerink Maintains Outperform on HCA Healthcare, Lowers Price Target to $304

SVB Leerink analyst Whit Mayo maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $320 to $304.